RxSight Inc (RXST US, +1, 22-May-24)

We ranked this stock +N on Feb. 16th based on an 8,000 share, $407,000 purchase from Juliet Bakker (Director since 2015) at an average price of $50.83. This stock has moved higher and it is unusual to see her make another large purchase, this time buying 5,000 shares, spending $305,000 at $61.09. This is now her second open market direct purchase. In 2023 she made both direct and indirect sales at lower prices. 

Bakker is a co-founder of Longitude Capital which once held a large position in the company and has been involved before the company’s IPO in August 2021 at $16 per share. In 2023 she made direct sales of approximately $2.5 million and sales on behalf of Longitude of $28 million, at an average price of $29.

The stock has moved up significantly after those sales and it is unusual to see these reversals and purchases from her, after such a price increase.  

We are upgrading the signal further, from +N (neutral positive) to +1 (strongly positive).